OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to ...

We appreciate the constructive remarks by Chung-Wei Christine Lin and colleagues regarding our systematic review and resulting recommendations.1 Our systematic review and meta-analysis were explicitly ...

Chief Executive Officer — Sandy Macrae Chief Development Officer — Nathalie Dubois-Stringfellow Head of Research and Technology — Gregory Davis Principal Financial Officer and Principal Accounting ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to ...

An American cancer patient living in the UK accused British cops of questioning her over an allegedly “threatening” message she’d posted on Facebook as part of the UK’s crackdown on online speech.

Poster #53: Listening to Patients with Diabetic Peripheral Neuropathic Pain: Insights from a Patient Survey to Inform Advanced Clinical Development of Pilavapadin Date: September 4, 2025 Time: 4:00 ...

A meta-analysis of randomized controlled trials found that gabapentinoids effectively reduced neuropathic pain and improved sleep in patients with spinal cord injury, but are associated with a higher ...

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit a snag on its path to expand the potential blockbuster’s reach into ...

Lauren Pastrana is the co-anchor of CBS4 News weeknights at 5, 6, 7 and 11 p.m. She joined CBS Miami in April 2012 as a reporter. She is an Emmy-nominated, multimedia journalist with experience in ...

TUESDAY, July 22, 2025 (HealthDay News) -- In a study published in the August issue of the American Journal of Ophthalmology, diagnostic indicators are identified for confirming chronic neuropathic ...